LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article ; Online: Prophylactic stenting for esophageal stricture prevention after endoscopic submucosal dissection.

    Shi, Ke-Da / Ji, Feng

    World journal of gastroenterology

    2017  Volume 23, Issue 6, Page(s) 931–934

    Abstract: Endoscopic submucosal dissection (ESD) of superficial esophageal cancer has been increasingly used as an alternative to surgery because it is minimally invasive and has a high rate of en bloc resection. However, a high rate of esophageal stricture is ... ...

    Abstract Endoscopic submucosal dissection (ESD) of superficial esophageal cancer has been increasingly used as an alternative to surgery because it is minimally invasive and has a high rate of en bloc resection. However, a high rate of esophageal stricture is observed after ESD for large lesions, which can dramatically decrease the patient's quality of life. Stricture prevention is necessary to allow for endoscopic therapy to expand. We, herein, review the most recent evidence and discuss the role of the metallic self-expandable stent and the biodegradable stent in esophageal stricture prevention. Limited studies suggested that prophylactic stenting could reduce the stricture rate without increasing the number of complications. In addition, the number of bougie dilation procedures was significantly lower with stent placement. Esophageal stenting is a promising option for post-ESD stricture prevention. However, current evidence is too preliminary to formulate practice standards. Future studies are needed to further validate the efficacy and safety of prophylactic stenting and determine the best strategy for stricture prevention. Stent migration is the most common complication. A new stent that has advantages of a low migration rate and minimal tissue reaction will need to be developed. Therefore, randomized controlled trials with long-term follow-up periods are required before prophylactic stenting could be considered a valid option to prevent post-ESD stricture.
    MeSH term(s) Absorbable Implants ; Endoscopic Mucosal Resection/adverse effects ; Esophageal Neoplasms/surgery ; Esophageal Stenosis/etiology ; Esophageal Stenosis/prevention & control ; Esophagoscopy/adverse effects ; Humans ; Postoperative Complications/etiology ; Postoperative Complications/therapy ; Quality of Life ; Self Expandable Metallic Stents
    Language English
    Publishing date 2017-02-14
    Publishing country United States
    Document type Editorial ; Review
    ZDB-ID 2185929-2
    ISSN 2219-2840 ; 1007-9327
    ISSN (online) 2219-2840
    ISSN 1007-9327
    DOI 10.3748/wjg.v23.i6.931
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Discovery of a Potent Antiosteoporotic Drug Molecular Scaffold Derived from

    Zou, Jian / Qiu, Zuo-Cheng / Yu, Qiang-Qiang / Wu, Jia-Ming / Wang, Yong-Heng / Shi, Ke-Da / Li, Yi-Fang / He, Rong-Rong / Qin, Ling / Yao, Xin-Sheng / Wang, Xin-Luan / Gao, Hao

    ACS central science

    2024  Volume 10, Issue 3, Page(s) 628–636

    Abstract: ... Angelica ... ...

    Abstract Angelica sinensis
    Language English
    Publishing date 2024-02-21
    Publishing country United States
    Document type Journal Article
    ISSN 2374-7943
    ISSN 2374-7943
    DOI 10.1021/acscentsci.3c01414
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: A Phytomolecule Icariin Protects from Sarcopenia Partially by Suppressing Myosin Heavy Chain Degradation in Orchiectomized Rats.

    Yang, Wen-Yao / Cao, Hui-Juan / Li, Ling / Huang, Cui-Shan / Shi, Ke-da / Sun, Antonia Ru-Jia / Qin, Ling / Wang, Xin-Luan

    Advanced biology

    2022  Volume 6, Issue 12, Page(s) e2200162

    Abstract: Treatments are lacking for sarcopenia, which is an age-related disease characterized by loss of skeletal muscle mass, strength, and/or physical performance. Icariin is a phytomolecule from herbal Epimedium, a traditional Chinese medicine widely used to ... ...

    Abstract Treatments are lacking for sarcopenia, which is an age-related disease characterized by loss of skeletal muscle mass, strength, and/or physical performance. Icariin is a phytomolecule from herbal Epimedium, a traditional Chinese medicine widely used to treat musculoskeletal disorders for thousands of years. Here the effects of icariin against sarcopenia are investigated and the underlying mechanism is elucidated. A classic rat model of bilaterally orchiectomized (ORX) is used to induce sarcopenia. After administration for 8 weeks, compared to the control group, the forelimb grip strength, the specific tetanic forces of the soleus (SOL) and extensor digitorum longus muscle (EDL) are higher, and the fiber cross-sectional areas (CSAs) of the gastrocnemius and tibialis anterior muscle are larger in the icariin group. In addition, icariin promotes mRNA and protein expressions of myosin heavy chain (MyHC) both in SOL and EDL. Mechanistically, icariin significantly suppresses the mRNA and protein expressions of FOXO3a, atrogin-1, and MuRF-1, which are related to the degradation of myosin heavy chain. Collectively, icariin protects from sarcopenia in ORX rats characterized by enhancing grip strength and skeletal muscle contraction, as well as increasing skeletal muscle CSA by inhibiting the ubiquitination degradation of the MyHC in skeletal muscle fibers.
    MeSH term(s) Animals ; Rats ; Muscle Contraction/physiology ; Myosin Heavy Chains/genetics ; RNA, Messenger/metabolism ; Sarcopenia/drug therapy ; Orchiectomy ; Male ; Flavonoids/pharmacology
    Chemical Substances icariin (VNM47R2QSQ) ; Myosin Heavy Chains (EC 3.6.4.1) ; RNA, Messenger ; Flavonoids
    Language English
    Publishing date 2022-08-26
    Publishing country Germany
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2701-0198
    ISSN (online) 2701-0198
    DOI 10.1002/adbi.202200162
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Blockage of ETS homologous factor inhibits the proliferation and invasion of gastric cancer cells through the c-Met pathway.

    Gu, Meng-Li / Zhou, Xin-Xin / Ren, Meng-Ting / Shi, Ke-Da / Yu, Mo-Sang / Jiao, Wen-Rui / Wang, Ya-Mei / Zhong, Wei-Xiang / Ji, Feng

    World journal of gastroenterology

    2020  Volume 26, Issue 47, Page(s) 7497–7512

    Abstract: Background: Gastric cancer (GC) is one of the most common and deadliest types of cancer worldwide due to its delayed diagnosis and high metastatic frequency, but its exact pathogenesis has not been fully elucidated. ETS homologous factor (EHF) is an ... ...

    Abstract Background: Gastric cancer (GC) is one of the most common and deadliest types of cancer worldwide due to its delayed diagnosis and high metastatic frequency, but its exact pathogenesis has not been fully elucidated. ETS homologous factor (EHF) is an important member of the ETS family and contributes to the pathogenesis of multiple malignant tumors. To date, whether EHF participates in the development of GC
    Aim: To investigate the role and mechanism of EHF in the occurrence and development of GC.
    Methods: The expression of EHF mRNA in GC tissues and cell lines was measured by quantitative PCR. Western blotting was performed to determine the protein expression of EHF, c-Met, and its downstream signal molecules. The EHF expression in GC tissues was further detected by immunohistochemical staining. To investigate the role of EHF in GC oncogenesis, small interfering RNA (siRNA) against EHF was transfected into GC cells. The cell proliferation of GC cells was determined by Cell Counting Kit-8 and colony formation assays. Flow cytometry was performed following Annexin V/propidium iodide (PI) to identify apoptotic cells and PI staining to analyze the cell cycle. Cell migration and invasion were assessed by transwell assays.
    Results: The data showed that EHF was upregulated in GC tissues and cell lines in which increased expression of c-Met was also observed. Silencing of EHF by siRNA reduced the proliferation of GC cells. Inhibition of EHF induced significant apoptosis and cell cycle arrest in GC cells. Cell migration and invasion were significantly inhibited. EHF silencing led to c-Met downregulation and further blocked the Ras/c-Raf/extracellular signal-related kinase 1/2 (Erk1/2) pathway. Additionally, phosphatase and tensin homolog was upregulated and glycogen synthase kinase 3 beta was deactivated. Moreover, inactivation of signal transducer and activator of transcription 3 was detected following EHF inhibition, leading to inhibition of the epithelial-to-mesenchymal transition (EMT).
    Conclusion: These results suggest that EHF plays a key role in cell proliferation, invasion, apoptosis, the cell cycle and EMT
    MeSH term(s) Cell Line, Tumor ; Cell Movement ; Cell Proliferation ; Epithelial-Mesenchymal Transition ; Gene Expression Regulation, Neoplastic ; Humans ; Neoplasm Invasiveness ; Stomach Neoplasms/genetics
    Language English
    Publishing date 2020-12-29
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2185929-2
    ISSN 2219-2840 ; 1007-9327
    ISSN (online) 2219-2840
    ISSN 1007-9327
    DOI 10.3748/wjg.v26.i47.7497
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top